Diagnostics legislation
This article was originally published in The Gray Sheet
Executive Summary
A Medicare reform bill for in vitro diagnostic tests could be introduced in Congress by the end of the month. AdvaMed and other interested groups are close to finding a sponsor on the Hill for the legislation, which will focus on modernizing the current Clinical Laboratory Fee Schedule to make it more rewarding to innovative new tests, according to a rep from the medical device trade association. The bill will follow some of the recommendations included in a Lewin Group report on "The Value of Diagnostics," released in July 2005 (1"The Gray Sheet" Aug. 1, 2005, p. 9)...
You may also be interested in...
AdvaMed Cites Lewin Group Study In Call For Updated CMS Diagnostic System
AdvaMed is calling on Congress to revamp Medicare's diagnostic payment system following the release of a Lewin Group study concluding that the current Clinical Laboratory Fee Schedule (CLFS) is "archaic, impractical and severely flawed.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.